Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Metrics to compare | INGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.6x | −14.8x | −0.5x | |
PEG Ratio | −0.17 | −0.19 | 0.00 | |
Price/Book | 0.9x | 4.2x | 2.6x | |
Price / LTM Sales | 0.5x | 5.4x | 3.2x | |
Upside (Analyst Target) | 106.7% | 72.0% | 51.4% | |
Fair Value Upside | Unlock | 22.1% | 7.1% | Unlock |